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Background: Methicillin-resistant Staphylococcus aureus (MRSA) has become one of the most prevalent pathogens
responsible for nosocomial infections throughout the world. As clinical MRSA diagnosis is concerned, current
diagnostic methodologies are restricted by significant drawbacks and novel methods are required for MRSA
detection. This study aimed at developing a simple loop-mediated isothermal amplification (LAMP) assay targeting
on orfX for the rapid detection of methicillin-resistance Staphylococcus aureus (MRSA).
Results: The protocol was designed by targeting orfX, a highly conserved open reading frame in S. aureus. One
hundred and sixteen reference strains, including 52 Gram-positive and 64 Gram-negative isolates, were included for
evaluation and optimization of the orfX-LAMP assay. This assay had been further performed on 667 Staphylococcus
(566 MRSA, 25 MSSA, 53 MRCNS and 23 MSCNS) strains and were comparatively validated by PCR assay using
primers F3 and B3, with rapid template DNA processing, simple equipments (water bath) and direct result determination
(both naked eye and under UV light) applied. The indispensability of each primer had been confirmed, and the optimal
amplification was obtained under 65°C for 45 min. The 25 μl reactant was found to be the most cost-efficient volume,
and the detection limit was determined to be 10 DNA copies and 10 CFU/reaction. High specificity was observed when
orfX-LAMP assay was subjected to 116 reference strains. For application, 557 (98.4%, 557/566) and 519 (91.7%, 519/566)
tested strains had been detected positive by LAMP and PCR assays. The detection rate, positive predictive value (PPV)
and negative predictive value (NPV) of orfX-LAMP were 98.4%, 100% and 92.7% respectively.
Conclusions: The established orfX-LAMP assay had been demonstrated to be a valid and rapid detection method
on MRSA.
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As a group of Gram-positive bacteria, staphylococci
strains are responsible for various tissues infection and a
wide range of diseases, including skin infections, pneumo-
nia, endocarditis, osteomyelitis, gastroenteritis, scalded
skin syndrome and toxic shock syndrome [1-4]. Within
species of staphylococci, Staphylococcus aureus has been
considered to be a major concern in both medicine and
food safety [1-3,5,6]. For other clinically significant* Correspondence: jyksys@126.com; yanmeili@live.cn
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stated.Staphylococcus strains, coagulase-negative staphylococci
(CoNS) strains have been reported as the most frequently
isolated pathogens in intravascular catheter related infec-
tions (CRI) (accounting for approximately 28% of nosoco-
mial bloodstream infection), thus become a frequent cause
of nosocomial infection and bacteremia, especially in pa-
tients with indwelling medical devices [7-9]. Since the first
report in 1961, methicillin-resistant Staphylococcus aureus
(MRSA) has become one of the most prevalent pathogens
responsible for nosocomial infections throughout the
world, which has raised a global challenge for clinicians,
hospital epidemiologists and administrators [10-16]. The
mecA gene, encoding the PBP2a protein and causing
methicillin resistance in staphylococci, is located on
staphylococcal cassette chromosome mec (SCCmec).This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 Electrophoresis of orfX-LAMP. A: Under different
temperatures. B: Detection limit, lane 1-8: negative control (distilled
water), DNA Marker, negative contro1 (template DNA sample of other
bacteria), 1 copies, 10 copies, 102 copies, 103 copies and 104 copies.
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and its regulators) and the ccr gene complex (encoding
site-specific recombinases responsible for the mobility of
SCCmec) [17-23]. In recent years, MRSA strains have been
considered to be a major example of the leading “Super
Bugs”, with broad resistance to practically all β-lactam anti-
biotics and usually other multiple drugs due to the associ-
ated resistance genes carried by SCCmec [1-3,17-20]. As
consequence, the increasing awareness for the risk and
hazard of MRSA strains raised the demands of an early,
cost-effective, timely, specific and sensitive detection assay
[5,6,10,20].
As clinical MRSA diagnosis is concerned, Staphylococcus
strains have commonly been identified via routine standard
procedures including colony morphology, Gram staining,
testing of catalase, hyaluronidase and coagulase, as well as
the Vitek 2 automated system and the API-Staph commer-
cial kit, which makes the detection of 16SrRNA somehow
irrelevant. However, despite the advantages of this assay, the
further development and broad application of multiplex-
PCR has been restricted by many factors, such as cross-
reaction of different sets of primers, self-inhibition due to
formation of dimmers, reduced amplification efficiency
caused by the simultaneous and parallel amplification,
undetectable influence of different targets, as well as
the requirement for standard full use of external and
internal quality control (both positive and negative control
for each targets) for each assay. As a novel analytical assay
since the past decade, mass spectrometry has been applied
for detection and diagnostics of various clinical microor-
ganisms, with advantages on high-throughput process,
sensitivity and specificity [24]. However, this method-
ology requires trained personnel, operating space, compli-
cated sample preparation procedure, as well as expensive
equipment.
In the last decade, loop-mediated isothermal amplifi-
cation (LAMP) had been reported as a novel nucleic
acid amplification method [25-27] (Figure 1) and applied
to the detection of various pathogenic organisms, includ-
ing Escherichia coli O157 with the associated toxins stx1
and stx2 [28], Yersinia pseudotuberculosis [29], Salmonella
[30-33], Vibrio parahaemolyticus with the associated
toxins tdh and trh [34-39], Psuedomonas aeruginosa [40]
and Listeria monocytogenes [41]. The LAMP methodology
relies on an auto-cycling strand displacement DNA syn-
thesis performed by the Bst DNA polymerase large frag-
ment under the isothermal conditions between 60-65°C,
and the amplicons are mixtures of many different sizes of
stem-loop DNAs with several inverted repeats of the tar-
get sequence and cauliflower-like structures with multiple
loops, which significantly simplify the reaction itself and
the result determination. The LAMP assay includes 4 or 6
primers (targeting on 6 or 8 specific regions) to perform
the amplification, and requires 45-60 min and 30-45 minwithout and with loop primers, respectively. In compari-
sion with PCR assay, the positive points of LAMP method
were simplicity, rapidity, specificity and sensitivity (10-
1000 times higher than PCR).
In the current study, a simple orfX-LAMP assay had
been developed, evaluated, optimized and further applied
Figure 2 Evaluation of orfX-LAMP assay under different time
points. A: Electrophoresis of orfX-LAMP reaction under different
time points: 1-10: DNA Marker, 15, 30, 45, 60, 75, 90, 105 and
120 min, negative control. B: Sybr Green of orfX-LAMP reaction
under different time points.
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approximately 60 mins for the whole process.
Results
Optimization of orfX-LAMP assay
The orfX-LAMP amplification had generated a large
number of ladder-like pattern bands on agarose gel due
to the characteristic structure up to the loading wells,
with a bottom band of 212-bp size amplicon obtained by
sequencing. OrfX-LAMP assay had been performed
under isothermal condition between 59°C and 66°C.
Despite none of significant difference observed, the elec-
trophoresis of LAMP products which were amplified under
64°C exhibited slightly larger amount of DNA amplicons
when compared to other temperatures (Figure 1), which
was consistent with studies previously. As reaction length
was concerned, various time points had been studied under
65°C and with 10 ng template DNA, including 15 min,
30 min, 45 min, 60 min, 75 min, 90 min, 105 min and
120 min. For the LAMP assay with loop primers, amplifica-
tion had been initially detected at 30 min, and reached
the maximal at 45 min (Figure 2). Nevertheless, with-
out loop primers, amplification products could not be
observed until 90 min. All amplicons of orfX-LAMP assay
had been determined by electrophoresis, with observation
directly by naked eye, as well as under UV light with Sybr
Green dyed (Figure 3).
Sensitivity and specificity of orfX-LAMP assays
The detection limit of orfX-LAMP assay had been stud-
ied by both minimal CFU of bacterial and template
DNA amount, which was found to be 10 copies of
DNA/tube and 10 CFU/reaction (LAMP was positive for
sample containing 1X104 CFU/ml, with 1 μl was in-
cluded in the reaction system) (Figure 1), in comparision
with the detection limit of PCR which was 102 copies of
DNA/tube and 103 CFU/reaction, indicating that the
sensitive of LAMP was 10-100 times sensitive than PCR.
As specificity was concerned, for primers, amplification
could not be obtained in the absence of FIP, BIP, F3 or
B3, due to the indispensable role each of the primers
plays in auto-cycling strand placement. The LAMP was
only performed in the existence of both inner primers
and outer primers. In addition, for the orfX-LAMP assay,
high specificity was acquired when this assay was sub-
jected to 116 reference strains, without any false positive
amplification for non-MRSA strains (Table 1).
Application of LAMP assays on clinical MRSA strains
After establishment and optimization, orfX-LAMP assay
were applied to the detection of 667 clinical Staphylococ-
cus strains, including 566 MRSA, 25 MSSA, 53 MRCNS
and 23 MSCNS strains (Table 2), with comparative valid-
ation by standard PCR assay. For application, rapid DNApreparation process, simple heating equipments and re-
sults determination by observation directly by naked eye
and under UV light had been applied. As shown by the re-
sults, for total of 566 MRSA strains, 557 (98.4%, 557/566)
and 519 (91.7%, 519/566) had been detected positive by
LAMP and PCR assays, respectively. However, for other
101 non MRSA isolates, none and 3 yielded positive amp-
lification. The detection rate, positive predictive value
(PPV) and negative predictive value (NPV) of orfX-LAMP
were 98.4%, 100% and 92.7%, respectively. All reaction had
been performed in triplicate to ensure reproducibility.
Discussion
As one of the globally widespread clinical pathogens,
MRSA strains have attained a heightened concern for its
Figure 3 Result determination of orfX-LAMP assays by color change. A: Results determination of orfX-LAMP by naked eyes. B: Results
determination of orfX-LAMP by Sybr Green with dark background, light backgrounds and under UV light. C: Results determination of orfX-LAMP
in application by Sybr Green.
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http://www.biomedcentral.com/1472-6750/14/8rapid and accurate detection, which has become a com-
mon issue in the diagnostics of MRSA. Current MRSA
diagnosis methodologies include routine standard proce-
dures (including colony morphology, Gram staining,
testing of catalase, hyaluronidase and coagulase), Vitek 2
automated system, API-Staph kit, immunological assays,
mass spectrometry, PCR (regular PCR and quantitative
PCR), etc. MRSA strains exhibit resistance to practically
all β-lactam antibiotics and commonly other drugs due
to the mecA and other resistance genes carried by
SCCmec. However, for type I (1B) and IV (2B) SCCmec
(with class B mec complex), the mecI-encoded repressorfunction may lead to the low-level methicillin resistance.
In the case of type II (2A) and III (3A) SCCmec (with
class A mec complex), the IS431-mediated deletion of
mecI and further derepression of mecA transcription
may cause the expression of methicillin resistance. As
consequence, differing from biochemical methodologies,
the accurate diagnostic identification of MRSA relies on
the detection of highly specific and conserved targets
within SCCmec. As orfX was considered to be highly
specific target for both S. aureus and SCCmec, a distinct-
ive MRSA detection methodology based on orfX-LAMP
was developed in the present study. In addition, a
Table 1 Reference strains included in the evaluation of
orfX-LAMP
Reference strains No. orfX
Gram-positive microorganisms
Methicillin-resistant Staphylococcus aureus 10442, COL, N315,
85/2082, CA05, JCSC 1978, JCSC 4469, MR108, M03-68, WIS
10 +
Methicillin-sensitive Staphylococcus aureus ATCC6358,
ATCC12598, ATCC12600, ATCC13150, ATCC13565,




S. epidermidis ATCC29887, ATCC700586
2 -
Methicillin-sensitive coagulase-negative staphylococci:
S. epidermidis ATCC12228, 6508, 9142, 9142-M10; S. haemolyticus
1922; S. hominis ATCC27844; S. capitis ATCC27840; S. saprophiticus
ATCC35552; S. sciuri ATCC29062; S. schleiferi ATCC43808;
S. intermedius ATCC49052
11 -
Listeria monocytogenes ATCC15313ATCC19111, ATCC19114,
ATCC19115, ATCC19116, ATCC19118, WF 03213, WF 06410,
WF 08211
8 -
Listeria invanovii ATCC19119, WF 06319 2 -
Listeria welshimeri WF 05086 1 -
Listeria seeligeri WF 04426 1 -




Escherichia coli O157: H7 WF01201 ATCC43889, NCTC12900 3 -
Escherichia coli O157: H7 WF07803, WF06544, WF05395 3 -
Escherichia coli O157: H7 WF04402, WF05311, WF06837 3 -
Escherichia coli O157: H7 WF04587, WF08385, WF06349 3 -
Escherichia coli O26: H11 WF054489 1 -
Escherichia coli O127: H6 WF073522 1 -
Escherichia coli O148: H28 WF063224 1 -
Escherichia coli C600 ATCC25922, ATCC43984, ATCC43985,
ATCC8739, C600, DH5α
6 -
Vibrio parahaemolyticus O1: K25 WF 04213 1 -
Vibrio parahaemolyticus O1: K56 WF 02314 1 -
Vibrio parahaemolyticus O3: K6 WF 04232 1 -
Vibrio parahaemolyticus O3: K6 WF 01031, WF 04506,
WF 06215
3 -
Vibrio parahaemolyticus O3: K6 WF 02321, WF 03218,
WF 05612
3 -
Vibrio parahaemolyticus O3: K12 WF 02108 1 -
Vibrio parahaemolyticus O3: K72 WF 02471 1 -
Vibrio parahaemolyticus O4: K37 WF 01309, WF 04238 2 -
Vibrio parahaemolyticus O4: K55 WF 03256, WF 07521 2 -
Vibrio parahaemolyticus O4: K68 WF 07926, WF 03422,
WF 02613
3 -
Vibrio parahaemolyticus O10: K28 WF 06438 1 -
Vibrio parahaemolyticus ATCC17802, ATCC27969 2 -
Vibrio vulnificus ATCC27562 1 -
Vibrio mimicus ATCC33653 1 -
Table 1 Reference strains included in the evaluation of
orfX-LAMP (Continued)
Psuedomonas aeruginosa ATCC 27853 1 -
Salmonella enterica ATCC13076, ATCC14028, ATCC19585,
ATCC29629
4 -
Salmonella typhimurium ATCC 14028, WF 04313 2 -
Salmonella choleraesuis ATCC 13312 1 -
Salmonella enteritidis WF 05148, WF 07086 2 -
Salmonella typhi WF 03201, WF 05026, WF 08138 3 -
Salmonella paratyphi WF 06426 1 -
Salmonella aberdeen WF 04542 1 -
Salmonella gallinarum WF 05938 1 -
Klebsiella pneumoniae ATCC 13883 1 -
Enterobacter cloacae ATCC 23355 1 -
Yersinia enterocolitica ATCC9610, ATCC27729 2 -
Total 116
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eration, specificity, sensitivity and expense, were also eval-
uated to verify the application of the orfX-LAMP assay for
MRSA detection. Targeting on six distinct regions, inner
and outer primers of the LAMP assay were highly specific
in comparison with conventional PCR techniques. In this
study, the specificity of the orfX-LAMP assay was verified
by indispensibility of each primer, without any false posi-
tive test obtained from reference strains and 100% PPV for




Bloodstream 100% (36/36) 94.4% (34/36)
Respiratory tract 98.6% (145147) 91.8% (135/147)
Skin and soft tissue 98.0% (238/243) 92.6% (225/243)
Urinary tract 98.6% (73/74) 91.9% (68/74)
Other 98.5% (65/66) 86.4% (57/66)
Subtotal 98.4% (557/566) 91.7% (519/566)
MSSA 0% (0/25) 0% (0/25)
MRCNS 0% (0/53) 0.0% (2/53)
MSCNS 0% (0/23) 0.0% (1/23)
Subtotal 0% (0/101) 0.0% (3/101)
Samples, Blood culture specimens included blood inoculated into aerobic and/
or anaerobic blood culture medium. Tracheal secretion specimens included
secretions from the trachea and bronchia and bronchoalveolar lavage fluid
specimens. Wound specimens included surgical wound specimens but also
specimens from ulcers, fistulae, abscesses, drainage fluids, catheters sites,
percutaneous endoscopic gastrostomy insertion sites, and tracheostomas.
Urine contained native urine from urinary catheters or bladder puncture and
inoculated culture systems. Other specimens consisted of skin swabs
specimens (from the nares, axilla, groin, or perianal area), as well as swab
specimens of the throat, tonsils, eye, ear, and vagina; body liquids;
puncture exudates.
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and previous LAMP detection methodoloy (ranging from
102-103 copies of DNA) [42], the detection limit of orfX-
LAMP was found to be 10 copies DNA/tube and 10 CFU/
reaction. For rapidity, approximate 60 min was required in
the application of orfX-LAMP, including DNA process,
isothermal reaction and result determination.
Conclusions
The first study on detection of MRSA by LAMP assay
was reported lately [6], however, 3 individual LAMP as-
says with targets including 16SrRNA, femA and mecA
were laborious and time and expense demanding. Also,
in another preliminary Staphylococcus LAMP identifica-
tion assay, 120 min and 2 targets (spaA and mecA) were
required for the procedure [42]. In this current study, a
simple LAMP assay targeting on orfX for rapid MRSA
detection had been developed, evaluated and optimized,
which required approximately 60 min for each test and
used the highly conserved target orfX. This orfX-LAMP
had been further applied to the detection of 667 clinical
Staphylococcus strains, and the sensitivity, specificity,
PPV and NPV were found to be 98.4%, 100%, 100% and
92.7%, respectively. In comparison with conventional
PCR, this established LAMP assay exhibited advantages
on detection limit, sensitivity, simplicity and rapidity. In
conclusion, this orfX-LAMP assay had been demonstrated
to be a valid and rapid detection method on MRSA, which




For development and evaluation of the orfX-LAMP
assay, 116 reference strains were included, with various
species of gram-negative and -positive isolates (Table 1).
As application was concerned, the optimized LAMP and
PCR assays was performed on a total of 667 Staphylococcus
strains, including 566 MRSA, 25 MSSA, 53 MRCNS andTable 3 The sequences and information of LAMP primers
Label 5′pos 3′pos len Tm 5′dG 3′dG
F3 204 222 19 56.03 −5.56 −4.06
B3 398 415 18 55.58 −7.53 −4.56
FIP 39
BIP 41
F2 243 261 19 55.33 −5.14 −4.71
F1c 291 310 20 61.82 −4.16 −5.45
B2 377 397 21 55.47 −4.51 −4.07
B1c 326 345 20 61.55 −3.92 −4.66
LF 266 286 21 61.30 −6.24 −5.45
LB 346 367 22 60.11 −5.26 −3.7323 MSCNS strains (Table 2), which had been previously
isolated from various clinical samples during 2001-2006
and preliminarily identified [6,9,15]. All strains were iden-
tified as S. aureus using standard procedures: colony
morphology, Gram staining, testing of catalase, hyaluroni-
dase and coagulase, the Vitek 2 automated system and the
API-Staph commercial kit. Methicillin resistance was de-
termined by susceptibility testing on oxacillin-screening
agar, confirmed by latex agglutination for PBP2a and
mecA detection by PCR [43].
Primer design
The protocol of this LAMP assay for rapid MRSA detec-
tion was designed to target on the specific orfX, which
located on the site of SCCmec and had been considered
to be a highly conserved open reading frame in S. aureus.
The sequences of orfX had been acquired on GenBank,
including SCCmec type I (NCTC 10442, AB033763),
SCCmec type II (N315, D86934), SCCmec type III (Mu50,
gi:57634611), CA05, MR108, 86-3P, M03-6, 43000,
SCCmec type V (WIS). A set of LAMP primers (Table 3)
targeting 8 distinct regions on orfX was designed via Pri-
merExplorer (V4), including forward inner primer (FIP)
with the complementary sequence of F1 (F1c), a T–T–T–T
linker and F2, backward inner primer (BIP) with the com-
plementary sequence of B1 (B1c), a T–T–T–T linker and
B2, the outer primers F3 and B3 located outside of the F2
and B2 regions, loop primers LF and LB located between
F2 and F1 or B1 and B2, respectively.
Establishment and optimization of orfX-Lamp assay
To evaluate and optimize the orfX-LAMP assay, 52
Gram-positive and 64 -negative isolates were employed
as reference strains. Cultural conditions and DNA ex-
traction of gram-negative and gram-positive strains were
performed as described previously [41,44-47]. In brief,
template DNA from S. aureus strains were prepared
from overnight Tryptic Soy Broth (TSB) cultures at 37°C
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EDTA. The suspension was boiled for 10 min and fur-
ther kept on ice. After centrifugation at 12,000 g for
3 min, the resulting supernatant was used as templates
for LAMP and PCR assays. Evaluation and optimization
of this orfX-LAMP assay included the study of mixture
volumn (4 volumns, with 12.5 μl, 25 μl and 50 μl), reac-
tion temperature (8 temperatures, with 59°C, 60°C, 61°C,
62°C, 63°C, 64°C, 65°C and 66°C), reaction time (8 time
points, with15 min, 30 min, 45 min, 60 min, 75 min,
90 min, 105 min and 120 min), specificity (including the
primers and strains) and detection limit. LAMP assays
was carried out in 3 different reaction mixture volumns,
containing 1.6 μM (each) of the primers FIP and BIP,
0.2 μM (each) of the primers F3 and B3, 0.8 μM (each)
of primers LF and LB, 1.6 mM of deoxynucleoside tri-
phosphates, 6 mM MgSO4, 1 M betain (Sigma, St. Louis,
MO, USA), 1 X thermopol buffer (New England Biolabs,
Ipswich, MA, USA), and specified amounts of target
genomic DNA. The reaction was initiated by heating at
95°C for 3 min, then chilled on ice for 30 sec, with 1 μl
(8 U) of Bst DNA polymerase (New England Biolabs,
Ipswich, MA, USA) further added. After incubation at
various temperatures ranging from 59°C to 66°C for
15 min-120 min, the reaction was terminated by heating
at 80°C for 2 min. As PCR assay was concerned, the
amplification was carried out in 50 μl reactant, using the
outer primers F3 and B3. The thermal profile was 94°C
for 5 min, followed by 30 cycles of 94°C for 30 sec, 50°C
for 30 sec, and 72°C for 30 sec and a final extension cycle
at 72°C for 7 min. The amplified products (5 μl/well) were
analyzed by gel electrophoresis in 2% agarose gels and
stained with ethidium bromide for 10 min. Template
DNA from MRSA 85/2082 was diluted for serial 10-fold
and the detection limit of LAMP and PCR assays were
ascertained by both minimal CFU of bacterial and plasmid
DNA (with orfX recombinated in a T vector). For LAMP
assays, the lowest bands from amplicons were sequenced
by an ABI PRISM 310 genetic analyzer (PE Biosystems,
Foster City, CA, USA).
Application of LAMP assays on clinical MRSA strains
After optimization, the orfX-LAMP assay had been fur-
ther performed on 667 Staphylococcus (566 MRSA, 25
MSSA, 53 MRCNS and 23 MSCNS) strains, and was
comparatively validated by standard PCR assay. Tem-
plate DNA was prepared through a rapid procedure as
aforementioned, with the required time as less than
30 min. Heating and isothermal amplification were sep-
arately performed on simple equipments including water
bath and heating block. Amplification products of
LAMP assay were dyed with Sybr Green, positive or
negative were determined through both visually observa-
tion of the color change by naked eye and a fluorescenceassay under UV [6,28,33]. This experiment was per-
formed in triplicate to ensure reproducibility.
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